Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas Meier | CEO, COO & Chairman of Group Executive Board | 587k | -- | 1968 |
| Mr. Alain Schaffter | Chief Financial Officer | -- | -- | 1977 |
| Mr. Michael Suter | Vice President of Global Accounting | -- | -- | -- |
| Dr. Gunther Loidl | Chief Technology Officer | -- | -- | 1970 |
| Mr. Achim Pluckebaum | Chief Information Officer | -- | -- | -- |
| Dr. Daniel Grotzky | Head of Group Communications | -- | -- | -- |
| Viviane Minden | Chief Human Resources Officer | -- | -- | -- |
| Dr. Anne-Kathrin Stoller Ph.D. | Chief Operating Officer of Bachem Americas, Inc. | -- | -- | 1974 |
| Dr. Torsten Wohr | Chief Commercial Officer | -- | -- | 1968 |
| Mr. Boris Corpataux | VP & Head Global Strategic Alliances | -- | -- | -- |
Bachem Holding AG
- Sector:
- Basic Materials
- Industry: Chemicals
- Full Time Employees:
- 2,207
Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.
Corporate Governance
Upcoming Events
February 27, 2025 at 6:00 AM UTC
Bachem Holding AG Earnings Date
May 5, 2025 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
April 30, 2024 at 12:00 AM UTC
Dividend Date